Annual publication summarizes major initiatives from 2023 and key priorities for 2024.
The American Cancer Society National HPV Vaccination Roundtable has released its annual impact report and action plan. The report provides a detailed overview of the roundtable’s major initiatives from last year. Some of the HPV Roundtable’s 2023 accomplishments include:
- Bringing new organizations into its national network,
- Hosting a health summit plan in collaboration with the Professional Collaborations team,
- Launching an early career development program,
- Hosting a joint national meeting with the American Cancer Society National Roundtable on Cervical Cancer.
ACS Director of Screening and Vaccination Dr. Debbie Saslow, who represented the Patient Support Pillar last month at a forum in the White House on advancing cervical cancer prevention, early detection, and survival, is one of the three tri-chairs of the Roundtable. Gabrielle Darville-Sanders, strategic director, National HPV Vaccination Roundtable, and Christina Turpin, director, National HPV Vaccination Roundtable, also contributed to the report.
The ACS and the Centers for Disease Control and Prevention founded the National HPV Vaccination Roundtable in 2014. It is a coalition of a public, private, and voluntary organizations with expertise relevant to increasing HPV vaccination rates in the U.S. as a way to reduce illness and death from HPV cancers, through coordinated leadership and strategic planning.
